Bram Smits
@bramsmits.bsky.social
I work where healthcare, tech, and policy collide—turning complexity into strategy. Occasionally making sense of EU policy. Lobbyist by day, dad of two always. All views my own (trust me, no one else wants them).
Another interesting insight: These tariffs may drive short-term disruptions but align with a deeper US strategic pivot toward economic sovereignty. Policymakers globally need to anticipate long-term structural shifts rather than temporary policy fluctuations.
April 4, 2025 at 2:35 PM
Another interesting insight: These tariffs may drive short-term disruptions but align with a deeper US strategic pivot toward economic sovereignty. Policymakers globally need to anticipate long-term structural shifts rather than temporary policy fluctuations.
Conflicting White House remarks about U.S. drug manufacturing add more confusion. It seems unlikely that pharma’s ‘exemptions’ will hold. What is certain is that constant policy shifts and uncertainty will further erode investor confidence.
April 3, 2025 at 8:51 AM
Conflicting White House remarks about U.S. drug manufacturing add more confusion. It seems unlikely that pharma’s ‘exemptions’ will hold. What is certain is that constant policy shifts and uncertainty will further erode investor confidence.
Ik was echt exact hetzelfde aan het denken toen ik het las 😅
March 18, 2025 at 7:33 PM
Ik was echt exact hetzelfde aan het denken toen ik het las 😅
Niet enkel oostwaarts, ook kijken hoe we zelf enkele stappen vooruit kunnen zetten. Hoe wakkeren we het Europees ondernemerschap weer aan en springen we mee op al deze trends...
March 17, 2025 at 11:44 PM
Niet enkel oostwaarts, ook kijken hoe we zelf enkele stappen vooruit kunnen zetten. Hoe wakkeren we het Europees ondernemerschap weer aan en springen we mee op al deze trends...
100% agreed, also wondering whether this should be driven by governments in this way.
March 17, 2025 at 11:33 PM
100% agreed, also wondering whether this should be driven by governments in this way.